Adjuvant nivolumab following salvage resection in head and neck squamous cell carcinoma patients previously treated with definitive therapy: A single-arm phase II multi-institutional study.

被引：4
|
作者：
Leddon, Jennifer
Haque, Sulsal
Gulati, Shuchi
Allen, Casey
Palackdharry, Sarah
Hamilton, Aubrey
Wilson, Sarah
Lanverman, Sheena M.
Riaz, Muhammad Kashif Kashif
Takiar, Vinita
Nagasaka, Misako
Patil, Yash
Zender, Chad
Jandarov, Roman
Tang, Alice L.
Cervenka, Brian
Zhang, Li
Sukari, Ammar
Wise-Draper, Trisha Michel
机构：
[1] Univ Cincinnati, Med Ctr, Cincinnati, OH 45267 USA
[2] Univ Michigan Hlth, Metro Hlth, Grand Rapids, MI USA
[3] Univ Cincinnati, Inst Canc, Cincinnati, OH USA
[4] Univ Cincinnati, Ctr Canc, Cincinnati, OH USA
[5] Univ Cincinnati, Clin Trials Inst, Cincinnati, OH USA
[6] Univ Cincinnati, Cincinnati, OH USA
[7] Barbara Ann Karmanos Canc Inst, Detroit, MI USA
[8] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.6031
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6031
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Interim analysis of a single arm phase II study of adjuvant nivolumab after salvage resection in head and neck squamous cell carcinoma patients previously treated with definitive therapy
    Wise-Draper, T.
    Haque, S.
    Steele, A.
    Desai, S.
    Harris, T.
    Riaz, M. K.
    Morris, J. C.
    Takiar, V.
    Nagasaka, M.
    Jandarov, R.
    Sukari, A.
    ANNALS OF ONCOLOGY, 2019, 30
  • [2] Phase II Trial of Adjuvant Nivolumab Following Salvage Resection in Patients with Recurrent Squamous Cell Carcinoma of the Head and Neck
    Leddon, Jennifer L.
    Gulati, Shuchi
    Haque, Sulsal
    Allen, Casey
    Palackdharry, Sarah
    Mathews, Maria
    Kurtzweil, Nicky
    Riaz, Muhammed Kashif
    Takiar, Vinita
    Nagasaka, Misako
    Patil, Yash
    Zender, Chad
    Tang, Alice
    Cervenka, Brian
    McGrath, Julie
    Korn, W. Michael
    Hinrichs, Benjamin H.
    Jandarov, Roman
    Harun, Nusrat
    Sukari, Ammar
    Wise-Draper, Trisha M.
    CLINICAL CANCER RESEARCH, 2022, 28 (16) : 3464 - 3472
  • [3] Neoadjuvant Nivolumab Therapy for Esophageal Squamous Cell Carcinoma: A Single-Arm, Phase II Study
    Park, Sehhoon
    Lee, Yurimi
    Lee, Jiyun
    Min, Yang Won
    Kim, Hong Kwan
    Chol, Joon Young
    Jung, Hyun Ae
    Choi, Yong Soo
    Choi, Yoon-La
    Shim, Young Mog
    Sun, Jong-Mu
    CANCER RESEARCH AND TREATMENT, 2024, 56 (02): : 567 - 579
  • [4] Factors related to outcome of salvage therapy for isolated cervical recurrence of squamous cell carcinoma in the previously treated neck: A multi-institutional study
    Krol, BJ
    Righi, PD
    Paydarfar, JA
    Cheng, ET
    Smith, RM
    Lai, DC
    Bhargava, V
    Piccirillo, JF
    Hayes, JT
    Lue, AJ
    Scher, RL
    Weisberger, EC
    Wilson, KM
    Tran, LE
    Rizk, N
    Pellitteri, PK
    Terris, DJ
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2000, 123 (04) : 368 - 376
  • [5] A multi-institutional phase 2 study of single agent nivolumab in previously treated metastatic squamous cell carcinoma of the anal canal (SCCA)
    Morris, V., II
    Ciombor, K.
    Salem, M.
    Nimeiri, H.
    Iqbal, S.
    Singh, P.
    Polite, B.
    Deming, D.
    Chan, E.
    Wade, J., III
    Bekaii-Saab, T.
    Wolff, R.
    Eng, C.
    ANNALS OF ONCOLOGY, 2016, 27 : 126 - 126
  • [6] Camrelizumab plus apatinib as induction therapy for locally advanced head and neck squamous cell carcinoma (IMplus): A single-arm phase II study.
    Ye, Lulu
    Zhang, Lin
    Li, Rongrong
    Dou, Shengjin
    Jiang, Wen
    Zhu, Guopei
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [7] A Randomized Multi-institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck
    Nathan, Cherie-Ann O.
    Hayes, D. Neil
    Karrison, Theodore
    Harismendy, Olivier
    Flores, Jose M.
    Moore-Medlin, Tara
    Vokes, Everett E.
    Gutkind, J. Silvio
    Neupane, Prakash
    Mills, Glenn
    Sargi, Zoukaa
    Seiwert, Tanguy
    Grilley-Olson, Juneko
    Day, Terry
    Gillison, Maura
    Wade, James L.
    Feldman, Lawrence
    Jha, Gautam
    Kozloff, Mark
    O'Leary, Miriam
    Worden, Francis P.
    Cohen, Ezra E. W.
    CLINICAL CANCER RESEARCH, 2022, 28 (23) : 5040 - 5048
  • [8] Phase II Multi-institutional Clinical Trial Result of Concurrent Cetuximab and Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
    Chung, Christine H.
    Li, Jiannong
    Steuer, Conor E.
    Bhateja, Priyanka
    Johnson, Matthew
    Masannat, Jude
    Poole, Maria I.
    Song, Feifei
    Hernandez-Prera, Juan C.
    Molina, Helen
    Wenig, Bruce M.
    Kumar, Sunil
    Kuperwasser, Charlotte
    Stephens, Philip J.
    Farinhas, Joaquim M.
    Shin, Dong M.
    Kish, Julie A.
    Muzaffar, Jameel
    Kirtane, Kedar
    Rocco, James W.
    Schell, Michael J.
    Saba, Nabil F.
    Bonomi, Marcelo
    CLINICAL CANCER RESEARCH, 2022, 28 (11) : 2329 - 2338
  • [9] Outcomes in patients with head and neck squamous cell carcinoma (HNSCC) requiring salvage resection after definitive therapy.
    Hague, Sulsal
    Riaz, Muhammad Kashif
    Hassan, Sarah
    Karivedu, Vidhya
    Ying, Jun
    Takiar, Vinita
    Draper, Trisha Michel Wise
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [10] Neoadjuvant tislelizumab plus chemotherapy followed by salvage surgery and adjuvant tislelizumab for recurrent head and neck squamous cell carcinoma after radiotherapy: A single-arm, phase II trial
    Wu, Wenjie
    Wang, Lin
    Zhang, Tong
    Zhang, Jie
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345